Clinical Trial Update: A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effects of sapropterin dihydrochloride on symptomatic peripheral arterial disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• Sapropterin dihydrochloride (Sapropterin dihydrochloride)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Intermittent Claudication | Phase 2 | Status: COMPLETED | Results posted: 2021-01-07